Trials
3 active
13 in total · 4 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Steno-occlusive Disease
- Main trialPhase 3
- “Compare the diagnostic performance of gadopiclenol against gadoterate meglumine in patients with vascular diseases of supra-aortic, peripheral, or abdominal / renal arteries using MRI”In the company’s words, NCT07348640 on ClinicalTrials.gov
- Other names
- Elucirem · Elucirem/Vueway · P03277
Coming up1
- 31 Dec 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials13
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 31 Dec 2027 | Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease | |
| Phase 3Completed | 11 Sep 2020 | Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) | |
| Phase 3Completed | 9 Dec 2020 | Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) | |
| Phase 3Completed | 28 Nov 2024 | Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas | |
| Phase 3Completed | 6 May 2025 | Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children | |
| Phase 2Completed | Jan 2018 | P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) | |
| Phase 2Completed | 18 Dec 2019 | Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI | |
| Phase 2Completed | 30 Sep 2024 | Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age | |
| Phase 1/2Completed | 17 Apr 2015 | Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions | |
| Phase 1Completed | 27 Jul 2021 | Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers | |
| Phase 4Ended | not given | Pilot study to explore the diagnostic value of gadopiclenol in pathological and radiological insights with multiparametric MRI enhancement in breast cancer. | |
| Phase 4Authorised | not given | Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of magnetic resonance imaging (MRI) diagnosis of perianal fistula associated with Crohn's disease | |
| Phase 3Authorised | not given | A Pilot Study on the Use of Gadopiclenol for Enhanced Cardiac MRI in Children with Congenital Heart Conditions: A self-controlled, non-randomised, open-label study to compare the image quality and diagnostic performance of gadopiclenol versus gadoterate meglumine |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026